2 years ago
JNJ
AnalystsMorten HerholdtMorten Herholdt's Stock Forecasts
AnalystsMorten Herholdt
Analyst Ranking
Bottom 17%
#4607 out of 5511 analysts
Average Return
-1.77%
Win Rate
60%9 out of 15
Risk vs Reward
Poor
Good
Morten Herholdt's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Bluebird Bio IncBLUE | +86.26% | $27.80 | $3.82 | 2024-03-05 - 2025-03-04 | Sell |
Amgen IncAMGN | +30.26% | $249.01 | $324.36 | 2023-09-06 - 2024-09-05 | Strong Buy |
Iqvia Holdings IncIQV | +13.40% | $218.82 | $248.14 | 2023-09-06 - 2024-09-05 | Strong Buy |
Gilead Sciences IncGILD | +12.88% | $129.61 | $146.30 | 2026-07-06 - 2026-09-15 | Strong Buy |
Johnson & JohnsonJNJ | +12.22% | $238.11 | $267.20 | 2026-03-17 - 2026-09-15 | Strong Buy |
Morten Herholdt Analyst Color
Get additional color on Morten Herholdt's coverage of popular stocks
3 years ago
JNJ
Morten Herholdt's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Amgen IncAMGN | 2 | Hold | $425.00 | +13.14% | Downgrades | 6 days ago |
Gilead Sciences IncGILD | 4 | Strong Buy | $175.00 | +19.62% | Maintains | 6 days ago |
Johnson & JohnsonJNJ | 3 | Strong Buy | $280.00 | +4.79% | Maintains | 6 months ago |
Labcorp Holdings IncLH | 2 | Strong Buy | N/A | N/A | Upgrades | 2 years ago |
Zoetis IncZTS | 2 | Strong Buy | $225.00 | N/A | Maintains | 2 years ago |
Biogen IncBIIB | 2 | Strong Buy | $342.00 | N/A | Maintains | 2 years ago |
Bluebird Bio IncBLUE | 2 | Sell | $20.40 | N/A | Maintains | 3 years ago |
Unitedhealth Group IncUNH | 1 | Hold | $540.00 | N/A | Initiates Coverage On | 3 years ago |
Livanova PLCLIVN | 1 | Hold | $52.00 | N/A | Initiates Coverage On | 3 years ago |
Iqvia Holdings IncIQV | 1 | Strong Buy | $260.00 | N/A | Initiates Coverage On | 3 years ago |
Actinium Pharmaceuticals IncATNM | 1 | Strong Buy | $11.60 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.